HOME > BUSINESS > Article

Text Size

small

medium

large


Fujifilm Unit Starts New Phase III Trial of Avigan for COVID-19

Fujifilm Unit Starts New Phase III Trial of Avigan for COVID-19

   Tokyo, April 21 (Jiji Press)--Fujifilm Toyama Chemical Co. said Wednesday that it has started a new Phase III clinical trial of its antiflu drug Avigan for use to treat COVID-19 patients in Japan.
   The Fujifilm Corp. unit applied last October for approval of Avigan as a treatment for patients with the coronavirus disease, but Japan's health ministry has found it difficult to confirm the drug's efficacy until now.

To read a full story, please click here to find out how to subscribe.

Aomori Tourism Information

HEADLINES

POLITICS
Japan to Enhance Border Control for Visitors from India to Block COVID Variants
ECONOMY
JR East to Cancel Service Reductions Friday Morning on 7 Tokyo-Area Lines
SPORTS
Sumo: All Wrestlers COVID-19 Negative ahead of Summer Tournament from Sunday
OTHER
Golden Week Passenger Traffic Surges from 2020, But Down Sharply from 2019

AFP-JIJI PRESS NEWS JOURNAL


Photos